Explore this issue:September 2014
Background: There have been concerns regarding the effectiveness of TORS as a treatment for early T-stage oropharyngeal carcinoma compared to existing treatment. Newer nonsurgical techniques have improved on traditional three-dimensional conformal radiotherapy by limiting the toxicity burden while offering similar disease control. One challenge in interpreting the literature is the patient heterogeneity reported.
Study design: Retrospective study of 20 cases reported through September 2012, including patients treated for early T-stage oropharynx cancer with TORS or IMRT.| | | Next → | Single Page